143 related articles for article (PubMed ID: 30396974)
1. Prognostic Significance of Conversion Surgery Following First- or Second-line Chemotherapy for Unresectable Gastric Cancer.
Fukuchi M; Mochiki E; Ishiguro T; Kumagai Y; Ishibashi K; Ishida H
Anticancer Res; 2018 Nov; 38(11):6473-6478. PubMed ID: 30396974
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Conversion Surgery Following S-1 plus Cisplatin or Oxaliplatin Chemotherapy for Unresectable Gastric Cancer.
Fukuchi M; Mochiki E; Ishiguro T; Ogura T; Sobajima J; Kumagai Y; Ishibashi K; Ishida H
Anticancer Res; 2017 Mar; 37(3):1343-1347. PubMed ID: 28314301
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].
Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1087-1092. PubMed ID: 30370504
[TBL] [Abstract][Full Text] [Related]
5. Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study.
Sato Y; Ohnuma H; Nobuoka T; Hirakawa M; Sagawa T; Fujikawa K; Takahashi Y; Shinya M; Katsuki S; Takahashi M; Maeda M; Okagawa Y; Naoki U; Kikuch S; Okamoto K; Miyamoto H; Shimada M; Takemasa I; Kato J; Takayama T
Gastric Cancer; 2017 May; 20(3):517-526. PubMed ID: 27553665
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
7. [Conversion Surgery following Second-Line Chemotherapy for Unresectable Gastric Cancer].
Ishiguro T; Mochiki E; Ito T; Ishikawa H; Yamamoto E; Sato T; Chikatani K; Yamamoto A; Chika N; Toyomasu Y; Hatano S; Kumagai Y; Ishibashi K; Maki A; Ishida H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1828-1830. PubMed ID: 35046344
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Recurrence After Curative Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Kimura A; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Anticancer Res; 2015 Nov; 35(11):6183-7. PubMed ID: 26504048
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer.
Kinoshita J; Fushida S; Tsukada T; Oyama K; Okamoto K; Makino I; Nakamura K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Ohta T
Eur J Surg Oncol; 2015 Oct; 41(10):1354-60. PubMed ID: 26028256
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of adjuvant surgery following chemotherapy for patients with initially unresectable stage IV gastric cancer.
Ito S; Oki E; Nakashima Y; Ando K; Hiyoshi Y; Ohgaki K; Saeki H; Morita M; Sakaguchi Y; Maehara Y
Anticancer Res; 2015 Jan; 35(1):401-6. PubMed ID: 25550579
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world.
Fanotto V; Cordio S; Pasquini G; Fontanella C; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Torri V; Aprile G
Gastric Cancer; 2017 Sep; 20(5):825-833. PubMed ID: 28028664
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Conversion Surgery for Gastric Cancer with Peritoneal Dissemination: A Retrospective Study.
Arigami T; Matsushita D; Okubo K; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Yanagita S; Uenosono Y; Ishigami S; Ohtsuka T; Natsugoe S
Oncology; 2020; 98(11):798-806. PubMed ID: 32906117
[TBL] [Abstract][Full Text] [Related]
13. Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment.
Kim SY; Yoon MJ; Park YI; Kim MJ; Nam BH; Park SR
Gastric Cancer; 2018 May; 21(3):453-463. PubMed ID: 28828688
[TBL] [Abstract][Full Text] [Related]
14. Conversion Surgery for Unresectable Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.
Du R; Hu P; Liu Q; Zhang J
Cancer Invest; 2019; 37(1):16-28. PubMed ID: 30632817
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy.
Beom SH; Choi YY; Baek SE; Li SX; Lim JS; Son T; Kim HI; Cheong JH; Hyung WJ; Choi SH; Jung M; Kim HS; Jeung HC; Chung HC; Rha SY; Noh SH
BMC Cancer; 2018 Nov; 18(1):1116. PubMed ID: 30442107
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
Fanotto V; Uccello M; Pecora I; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Ferrari L; Bordonaro R; Vivaldi C; Gerratana L; Bozzarelli S; Filippi R; Bilancia D; Russano M; Aprile G
Oncologist; 2017 Dec; 22(12):1463-1469. PubMed ID: 28860412
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers.
Seo S; Park SJ; Ryu MH; Park SR; Ryoo BY; Park YS; Na YS; Lee CW; Lee JK; Kang YK
Oncotarget; 2017 May; 8(20):33844-33854. PubMed ID: 27802183
[TBL] [Abstract][Full Text] [Related]
18. [Progress in conversion therapy for originally unresectable gastric cancer].
Chen X; Lin Z; Chen Y; Luo J; Zhu Y; Liu H; Li G; Yu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1191-1195. PubMed ID: 30370519
[TBL] [Abstract][Full Text] [Related]
19. Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.
Mieno H; Yamashita K; Hosoda K; Moriya H; Higuchi K; Azuma M; Komori S; Yoshida T; Tanabe S; Koizumi W; Katada N; Watanabe M
Surg Today; 2017 Oct; 47(10):1249-1258. PubMed ID: 28365892
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and Safety of FOLFIRI after Failure of FOLFOX-4 in Advanced Gastric Cancer].
Kwon HJ; Park MI; Park SJ; Moon W; Kim SE; Lee HW; Choi YJ; Kim JH
Korean J Gastroenterol; 2015 Jul; 66(1):10-6. PubMed ID: 26194124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
